Similar Papers

Paper Title
Journal
Date
Author
CSF1R Is Associated with Poor Overall Survival in AML and Mediates Supportive Interactions Between AML and Stromal Cells in the AML Microenvironment
Ayesha Rashid ... Mark D Minden
Blood | VOL. 128
Ayesha Rashid, et. al.Ayesha Rashid ... Mark D Minden
02 Dec 2016
The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells
Sigal Tavor ... Michal Abraham
Blood | VOL. 122
Sigal Tavor, et. al.Sigal Tavor ... Michal Abraham
15 Nov 2013
Characterization of Mesenchymal Stromal Cells (MSCs) Derived From Acute Myeloid Leukemia (AML) Bone Marrow
Soumit K Basu ... Pamela S Becker
Blood | VOL. 118
Soumit K Basu, et. al.Soumit K Basu ... Pamela S Becker
18 Nov 2011
Bone Marrow Stroma Protects FLT3 Acute Myeloid Leukemia (AML) through CYP3A4-Mediated Drug Metabolization of FLT3 Tyrosine Kinase Inhibitors (TKIs)
Yu-Ting Chang ... Richard J Jones
Blood | VOL. 130
Yu-Ting Chang, et. al.Yu-Ting Chang ... Richard J Jones
25 Jun 2021
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor-specific antibodies.
Dennis L Cooper ... Amit Verma
British journal of haematology | VOL. -
Dennis L Cooper, et. al.Dennis L Cooper ... Amit Verma
06 Feb 2025
Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML.
John Chadwick ... Emma Searle
British journal of haematology | VOL. -
John Chadwick, et. al.John Chadwick ... Emma Searle
30 Jan 2025
T-cell-based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic.
S Moraru ... Laure Ricard
British journal of haematology | VOL. -
S Moraru, et. al.S Moraru ... Laure Ricard
29 Jan 2025
First relapse in older adults with multiple myeloma: Creating new pathways in uncharted territory.
Tanya M Wildes
British journal of haematology | VOL. -
Tanya M WildesTanya M Wildes
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.